| Title: | Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations |
| Journal: | iScience |
| Published: | 17 Jun 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39040076/ |
| DOI: | https://doi.org/10.1016/j.isci.2024.110298 |
Publication 11746
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Fecal metabolites effectively discriminate inflammatory bowel disease (IBD) and show differential associations with diet. Metabolomics and AI-based models, including explainable AI (XAI), play crucial roles in understanding IBD. Using datasets from the UK Biobank and the Human Microbiome Project Phase II IBD Multi'omics Database (HMP2 IBDMDB), this study uses multiple machine learning (ML) classifiers and Shapley additive explanations (SHAP)-based XAI to prioritize plasma and fecal metabolites and analyze their diet correlations. Key findings include the identification of discriminative metabolites like glycoprotein acetyl and albumin in plasma, as well as nicotinic acid metabolites andurobilin in feces. Fecal metabolites provided a more robust disease predictor model (AUC [95%]: 0.93 [0.87-0.99]) compared to plasma metabolites (AUC [95%]: 0.74 [0.69-0.79]), with stronger and more group-differential diet-metabolite associations in feces. The study validates known metabolite associations and highlights the impact of IBD on the interplay between gut microbial metabolites and diet.</p>
4 Authors
- Serena Onwuka
- Laura Bravo-Merodio
- Georgios V. Gkoutos
- Animesh Acharjee
Enabling scientific discoveries that improve human health